Lifecore Biomedical, Inc. \De\ (LFCR)Alpha Wave Global, LP reduced its stake -44K shares
Alpha Wave Global, LP reduced its stake in Lifecore Biomedical, Inc. \De\, per its Q1 2025 13F.
- 72K
- Shares reported · -44K vs prior quarter
- 0.23%
- Disclosed portfolio weight
- $509K
- Reported value
- Holdings as of
- Mar 31, 2025
- Filed
- May 14, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- May 5, 2025Insider10% owner sold ~$174K of LFCR shares in the open market
- May 6, 2025Insider10% owner sold ~$4.9K of LFCR shares in the open market
- May 7, 2025Insider10% owner sold ~$111K of LFCR shares in the open market
- May 8, 2025Insider10% owner sold ~$36K of LFCR shares in the open market
- May 9, 2025Insider10% owner sold ~$4.9K of LFCR shares in the open market
- May 12, 2025Insider10% owner sold ~$321K of LFCR shares in the open market
- May 13, 2025Insider10% owner sold ~$86K of LFCR shares in the open market
What came next
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Lifecore Biomedical, Inc. \De\
OQRO holds no insider, Congress, fund or contract record for Lifecore Biomedical, Inc. \De\ dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LFCR page.
How this filing works
Other disclosures at Lifecore Biomedical, Inc. \De\
- SEC Form 4May 29, 2025
- SEC Form 4May 29, 2025
- SEC Form 4May 29, 2025
- SEC Form 4May 16, 2025
- SEC Form 4May 12, 2025
- SEC Form 4May 12, 2025
Everything OQRO holds on this company is on its LFCR page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data